RETISIO Hires Enterprise Software Sales Veteran to Lead Business Development
FRISCO,
A veteran of the ECommerce Enterprise Software industry with Adobe, Oracle and SAP, Meehan joins the company after having served as a sales leader for Mirakl and Amplience during their early growth stages.
"RETISIO Reactive ECommerce provides state of the art capabilities, with tremendous flexibility and scalability. It represents the strongest alternative platform for companies moving away from legacy systems of the past," Meehan said. "I am thrilled to join the team. The vision and experience of the co-founders and management team are evident in the solutions we can offer customers."
Meehan joins RETISIO as the company continues to see strong demand for its ECommerce suite, which offers a platform designed for retail and commerce businesses. As companies are innovating their customer models, its unique platform capabilities address complex commerce operating models, such as integrated, multi-vendor ECommerce marketplaces which deliver unified and seamless shopping experiences.
Founder and CEO,
About RETISIO
RETISIO is the leading provider of advanced ECommerce solutions that empower modern retailers and brands to sell more online and reduce risk. The platform's advanced technology leverages RETISIO's powerful Reactive and Composable Commerce capabilities. Its full suite of products includes RETISIO Commerce, Intelligent Search, Content, Promotions, Intelligent Recommendations, Dartmouth AI, and Analytics. For more information, visit www.retisio.com.
Media Contact:
1-888-627-7657
[email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/retisio-hires-enterprise-software-sales-veteran-to-lead-business-development-302030689.html
SOURCE RETISIO Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- In HelloNation, Tax Expert Sal Julian Details Which Itemized Deductions High-Income Individuals Lose Without Knowing It
- Bristol Myers Squibb Presents Data Up to Five Years Reinforcing the Long-Term Efficacy and Safety of Camzyos (mavacamten) in Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM) at the European
- Meant Earns LegitScript Certification for Its Online GLP-1 Weight Care Platform
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share